Retraction to: Correlations of IFN-γ genetic polymorphisms with susceptibility to breast cancer: a meta-analysis (Tumor Biol., (2014), 35, (6867-6877), DOI 10.1007/s13277-014-1856-6);Correlations of IFN-γ genetic polymorphisms with susceptibility to breast cancer: A meta-analysis

Tumor Biology

Volumn 35, Issue 7, 2014, Pages 6867-6877

  Li, Chun Jiang ^a,b   Dai, Yue ^b   Fu, Yan Jun ^b   Tian, Jia Ming ^b   Li, Jin Lun ^b   Lu, Hong Jun ^b   Duan, Feng ^b   Li, Qing Wang ^a,c  

^a YANSHAN UNIVERSITY   (China)

^b JIAMUSI UNIVERSITY   (China)

^c NORTHWEST A F UNIVERSITY   (China)

Author keywords

Breast cancer; Genetic polymorphism; IFN ; Meta analysis; Susceptibility

Indexed keywords

GAMMA INTERFERON;

ARTICLE; ASIAN; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHINESE; CLINICAL TRIAL; ETHNICITY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; PRIORITY JOURNAL;

ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERFERON-GAMMA; RISK FACTORS;

EID: 84905023475     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-3699-1     Document Type: Erratum

References (33)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69-90.
2. Guo LJ, Zhang QY. Decreased serum miR-181a is a potential new tool for breast cancer screening. Int J Mol Med. 2012;30(3):680-6.
3. Brinton LA, Carreon JD, Gierach GL, McGlynn KA, Gridley G. Etiologic factors for male breast cancer in the U.S. Veterans Affairs medical care system database. Breast Cancer Res Treat. 2010;119(1):185-92.
4. Nickels S, Truong T, Hein R, Stevens K, Buck K, Behrens S, et al. Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors. PLoS Genet. 2013;9(3):e1003284.
5. La Vecchia C, Giordano SH, Hortobagyi GN, Chabner B. Overweight, obesity, diabetes, and risk of breast cancer: interlocking pieces of the puzzle. Oncologist. 2011;16(6):726-9.
6. Xue F, Willett WC, Rosner BA, Hankinson SE, Michels KB. Cigarette smoking and the incidence of breast cancer. Arch Intern Med. 2011;171(2):125-33.
7. Park SK, Kim Y, Kang D, Jung EJ, Yoo KY. Risk factors and control strategies for the rapidly rising rate of breast cancer in Korea. J Breast Cancer. 2011;14(2):79-87.
8. Fontein DB, de Glas NA, Duijm M, Bastiaannet E, Portielje JE, Van de Velde CJ, et al. Age and the effect of physical activity on breast cancer survival: a systematic review. Cancer Treat Rev. 2013;39(8):958-65.
9. Reiner AS, John EM, Brooks JD, Lynch CF, Bernstein L, Mellemkjaer L, et al. Risk of asynchronous contralateral breast cancer in noncarriers of BRCA1 and BRCA2 mutations with a family history of breast cancer: a report from the Women's Environmental Cancer and Radiation Epidemiology Study. J Clin Oncol. 2013;31(4):433-9.
10. Bouchardy C, Rapiti E, Fioretta G, Schubert H, Chappuis P, Vlastos G, et al. Impact of family history of breast cancer on tumour characteristics, treatment, risk of second cancer and survival among men with breast cancer. Swiss Med Wkly. 2013;143:w13879.
11. Su Y, Tang LY, Chen LJ, He JR, Su FX, Lin Y, et al. Joint effects of febrile acute infection and an interferon-gamma polymorphism on breast cancer risk. PLoS One. 2012;7(5):e37275.
12. Karakus N, Kara N, Ulusoy AN, Ozaslan C, Bek Y. Tumor necrosis factor alpha and beta and interferon gamma gene polymorphisms in Turkish breast cancer patients. DNA Cell Biol. 2011;30(6):371- 7.
13. Kim K, Cho SK, Sestak A, Namjou B, Kang C, Bae SC. Interferon-gamma gene polymorphisms associated with susceptibility to systemic lupus erythematosus. Ann Rheum Dis. 2010;69(6):1247-50.
14. Horras CJ, Lamb CL, Mitchell KA. Regulation of hepatocyte fate by interferon-gamma. Cytokine Growth Factor Rev. 2011;22(1):35-43.
15. He JR, Chen LJ, SuY, Cen YL, Tang LY, Yu DD, et al. Joint effects of Epstein-Barr virus and polymorphisms in interleukin-10 and interferon-gamma on breast cancer risk. J Infect Dis. 2012;205(1):64-71.
16. Chou SF. Development of a manual self-assembled colloidal gold nanoparticle-immunochromatographic strip for rapid determination of human interferon-gamma. Analyst. 2013;138(9):2620-3.
17. Pluddemann A, Mukhopadhyay S, Gordon S. Innate immunity to intracellular pathogens: macrophage receptors and responses to microbial entry. Immunol Rev. 2011;240(1):11-24.
18. Gonullu G, Basturk B, Evrensel T, Oral B, Gozkaman A, Manavoglu O. Association of breast cancer and cytokine gene polymorphism in Turkish women. Saudi Med J. 2007;28(11):1728-33. (Pubitemid 350244364)
19. Naylor SL, Gray PW, Lalley PA. Mouse immune interferon (IFN-gamma) gene is on chromosome 10. Somat Cell Mol Genet. 1984;10(5):531-4. (Pubitemid 14039235)
20. Erdei E, Kang H, Meisner A, White K, Pickett G, Baca C, et al. Polymorphisms in cytokine genes and serum cytokine levels among New Mexican women with and without breast cancer. Cytokine. 2010;51(1):18-24.
21. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies inmeta-analyses. Eur J Epidemiol. 2010;25(9):603-5.
22. Zintzaras E, Ioannidis JP. HEGESMA: genome search meta-analysis and heterogeneity testing. Bioinformatics. 2005;21(18):3672-3. (Pubitemid 41264106)
23. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA. 2006;295(6):676-80. (Pubitemid 43209069)
24. Wu GH, Zhang JY, Lu PX. Association of single nucleotide polymorphism of interferon-ganuna gene+874 site and breast cancer. Cancer Res Prev Treat. 2008;35(9).
25. Skerrett DL, Moore EM, Bernstein DS, Vahdat L. Cytokine genotype polymorphisms in breast carcinoma: associations of TGF-beta1 with relapse. Cancer Invest. 2005;23(3):208-14. (Pubitemid 40770738)
26. Wu JM, Bensen-Kennedy D, Miura Y, Thoburn CJ, Armstrong D, Vogelsang GB, et al. The effects of interleukin 10 and interferon gamma cytokine gene polymorphisms on survival after autologous bone marrow transplantation for patients with breast cancer. Biol Blood Marrow Transplant. 2005;11(6):455-64. (Pubitemid 40753798)
27. Saha A, Dhir A, Ranjan A, Gupta V, Bairwa N, Bamezai R. Functional IFNG polymorphism in intron 1 in association with an increased risk to promote sporadic breast cancer. Immunogenetics. 2005;57(3-4):165-71. (Pubitemid 40775573)
28. Kamali-Sarvestani E, Merat A, Talei AR. Polymorphism in the genes of alpha and beta tumor necrosis factors (TNF-alpha and TNF-beta) and gamma interferon (IFN-gamma) among Iranian women with breast cancer. Cancer Lett. 2005;223(1):113-9. (Pubitemid 40693715)
29. Zur Hausen H. The search for infectious causes of human cancers: where and why. Virology. 2009;392(1):1-10.
30. Joshi D, Quadri M, Gangane N, Joshi R. Association of Epstein Barr virus infection (EBV) with breast cancer in rural Indian women. PLoS One. 2009;4(12):e8180.
31. Farrell RA, Antony D, Wall GR, Clark DA, Fisniku L, Swanton J, et al. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI. Neurology. 2009;73(1):32-8.
32. Wingate PJ, McAulay KA, Anthony IC, Crawford DH. Regulatory T cell activity in primary and persistent Epstein-Barr virus infection. J Med Virol. 2009;81(5):870-7.
33. Mi YY, Yu QQ, Xu B, Zhang LF, Min ZC, Hua LX, et al. Interferon gamma +874 T/A polymorphism contributes to cancer susceptibility: a meta-analysis based on 17 case-control studies. Mol Biol Rep. 2011;38(7):4461-7.